JP Morgan Chase
BBNX

JP Morgan Chase’s Beta Bionics BBNX Stock Holding History

JP Morgan Chase’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.03M Sell
307,229
-41,442
-12% -$613K ﹤0.01% 3765
2025
Q4 		$10.6M Buy
348,671
+142,716
+69% +$3.81M ﹤0.01% 2621
2025
Q3 		$4.09M Buy
205,955
+199,785
+3,238% +$3.51M ﹤0.01% 3534
2025
Q2 		$89.8K Sell
6,170
-90
-1% -$1.27K ﹤0.01% 5652
2025
Q1 		$76.6K Buy
+6,260
New +$117K ﹤0.01% 5694

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase's BBNX Position: Q1 2026 in Review

JP Morgan Chase reduced its Beta Bionics (BBNX) stake by 12% in Q1 2026, selling an estimated $613K and leaving 307,229 shares worth $3.03M. The position accounts for ﹤0.01% of the portfolio, ranked #3765.

JP Morgan Chase first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $10.6M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • JP Morgan Chase held 307,229 shares of Beta Bionics worth $3.03M as of Q1 2026.
  • JP Morgan Chase sold 41,442 Beta Bionics shares in Q1 2026, an estimated $613K.
  • Beta Bionics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3765 holding.
  • JP Morgan Chase first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • JP Morgan Chase's Beta Bionics position peaked at $10.6M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.